Estas son las publicaciones del RELCP:

• Falkenhain-Lopez D, Muniesa C, Estrach MT, Morillo-Andujar M, Penate Y, Acebo E et al. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermosifiliogr 2023; 114: 291-8.
• Muniesa C, Gallardo F, Garcia-Doval I, Estrach MT, Combalia A, Morillo-Andujar M et al. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. J Eur Acad Dermatol Venereol 2022.
• Torre-Castro J, Estrach T, Penate Y, Acebo E, Fernandez de Misa R, Blanes M, et al. Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry. Pediatr Dermatol. 2021;38(6):1506-9.
• Sanchez-Velazquez A, Bauer-Alonso A, Estrach T, Vega-Diez D, Garcia-Muret P, Haya L, et al. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. J Eur Acad Dermatol Venereol. 2021;35(10):e624-e6.
• Muniesa C, Domingo-Domenech E, Fornons-Servent R, Penate Y, Estrach MT, Ramon MD, et al. Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. J Eur Acad Dermatol Venereol 2023; 37: 57-64.
• Penate Y, Servitje O, Machan S, Fernandez-de-Misa R, Estrach MT, Acebo E, et al. The First Year of the AEVD Primary Cutaneous Lymphoma Registry. Actas Dermosifiliogr. 2018;109(7):610-6.
• Estrach T, Servitje O, Ortiz-Romero PL. AEDV Primary Cutaneous Lymphoma Registry. Actas Dermosifiliogr. 2017;108(3):181-3.